Abstract:Mutations in the SZT2 gene have been associated with developmental and epileptic encephalopathy-18, a rare severe autosomal recessive neurologic disorder, characterized by psychomotor impairment/intellectual disability, dysmorphic facial features and early onset of refractory seizures. Here we report the generation of the first induced pluripotent stem cell (iPSC) lines from a patient with treatment-resistant epilepsy, carrying compound heterozygous mutations in SZT2 (Mut1: c.498G>T and Mut2: c.6553C>T), and his healthy heterozygous parents. Peripheral blood mononuclear cells were reprogrammed by a non-integrating Sendai virus-based reprogramming system. The generated human iPSC lines exhibited expression of the main pluripotency markers, the potential to differentiate into all three germ layers and presented a normal karyotype. These lines represent a valuable resource to study neurodevelopmental alterations, and to obtain mature, pathology-relevant neuronal populations as an in vitro model to perform functional assays and test the patient’s responsiveness to novel antiepileptic treatments.

Establishment of a Transgene-Free Ips Cell Line (Sdchi007-A) from a Young Patient Bearing a ATP1A2 Mutation and Suffering from Epilepsy

Establishment of a transgene-free iPS cell line (SDCHi008-A) from a young patient bearing a KCNQ2 mutation and suffering from Epilepsy

Establishment of a transgene-free iPS cell line (SDCHi002-A) from a young patient bearing a NPRL3 mutation and suffering from Epilepsy

Establishment of a transgene-free iPS cell line (SDCHi003-A) from a young patient bearing a NPRL2 mutation and suffering from Epilepsy

Establishment of Induced Pluripotent Stem Cell Line (Zzui009-A) from an Alzheimer's Disease Patient Carrying a PSEN1 Gene Mutation

Generation of an induced pluripotent stem cell line (ZJUi013-A) from a Familial cortical myoclonic tremor with epilepsy type 1 patient carrying (TTTCA)n insertion in the SAMD12 gene

Establishment of Induced Pluripotent Stem Cell Line (Zzui010-A) from an Alzheimer's Disease Patient Carrying an APP Gene Mutation.

Generation of Induced Pluripotent Stem Cell Line (Zzui007-A) from a 52-Year-old Patient with a Novel CHCHD2 Gene Mutation in Parkinson's Disease.

Generation of a Human Induced Pluripotent Stem Cell Line from an Epilepsy Patient Carrying Mutations in the PIK3R2 Gene

Generation of the SCN1A Epilepsy Mutation in Hips Cells Using the TALEN Technique

Induced Pluripotent Stem Cell (iPSC) Lines from a Family with Resistant Epileptic Encephalopathy Caused by Compound Heterozygous Mutations in SZT2 Gene

Generation of a human induced pluripotent stem cell (iPSC) line from a patient with a CDKL5 gene mutation

Generation of an Induced Pluripotent Stem Cell Line from a Long QT Syndrome Patient Carrying KCNH2/1956C > A Mutation.

Establishment of a transgene-free iPS cell line (SDQLCHi046-A) from a young patient bearing a HDAC8 mutation and suffering from Cornelia de Lange Syndrome

A Heterozygous SCN1A (c.a5768g/+) Mutant Human Induced Pluripotent Stem Cell Line (Ustci002-A) Generated Using TALEN-mediated Precise Gene Editing

Generation of a Human Induced Pluripotent Stem Cell Line (Cipi002-A) from an Early Infantile Epileptic Encephalopathy Patient with a Heterozygous Mutation in SCN8A

Generation of Induced Pluripotent Stem Cell Line, ZJUCHi002-A, from Charcot-Marie-Tooth Disease Type 2A (CMT2A) Patient with a Mutation of C.752c>t in MFN2

Generation and Characterization of an Ips Cell Line (Pumci006-A) from Skin Fibroblasts of a Patient with an M239T Mutation in PSEN2 Gene

Establishment of iPS cell line (SDQLCHi061-A) from a patient with carbamoylphosphate synthetase I deficiency due to CPS1 mutation

Generation of a Human Charcot-Marie-Tooth Disease Type 1B (CMT1B) Ipsc Line, ZJUCHi001-A, with a Mutation of C.292c>t in MPZ.

Establishment Of An Induced Pluripotent Stem Cell Line (Zjshi001-A) From A Patient With Epileptic Encephalopathy Carrying Kcnb1 Glu330asp Mutation